|
HS Code |
506538 |
| Generic Name | Chlorambucil |
| Brand Names | Leukeran |
| Drug Class | Alkylating agent |
| Chemical Formula | C14H19Cl2NO2 |
| Molecular Weight | 304.22 g/mol |
| Route Of Administration | Oral |
| Indications | Chronic lymphocytic leukemia, Hodgkin's lymphoma, non-Hodgkin's lymphoma |
| Mechanism Of Action | Cross-links DNA, inhibiting DNA replication and transcription |
| Side Effects | Bone marrow suppression, nausea, vomiting, anemia, leukopenia |
| Contraindications | Hypersensitivity to chlorambucil, pregnancy |
| Pregnancy Category | D |
| Storage Conditions | Store at 2°C to 8°C (refrigerated) |
| Atc Code | L01AA02 |
As an accredited Chlorambucil factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Chlorambucil packaging features a white and blue box, clearly labeled, containing 25 tablets (2 mg each), with safety and dosage instructions. |
| Shipping | Chlorambucil is shipped as a hazardous material, requiring secure, temperature-controlled packaging to prevent degradation and exposure. The container must be clearly labeled according to regulatory standards. Handling and transport are restricted to authorized personnel, and documentation, including Safety Data Sheets (SDS), must accompany the shipment to ensure safe delivery and compliance. |
| Storage | Chlorambucil should be stored in a tightly closed container, protected from light and moisture. Keep it at controlled room temperature, ideally between 20°C to 25°C (68°F to 77°F). Store away from incompatible substances and out of reach of children. Proper storage conditions help preserve the drug’s stability and prevent degradation or loss of potency. |
Applications of Chlorambucil in Industrial ManufacturingChlorambucil serves as a niche, high-value alkylating agent with established uses in pharmaceutical manufacturing environments. Below, we present detailed downstream applications based on real industrial scenarios, each with specific compliance, process, and product chain considerations. 1. Active Pharmaceutical Ingredient (API) Production for Oncology DrugsChlorambucil acts as a primary API in the synthesis of certain therapeutic agents indicated for chronic lymphocytic leukemia, Hodgkin’s lymphoma, and related hematological malignancies. The material undergoes stringent synthesis steps, purification, and crystallization under regulated cleanroom conditions. Final manufacturing requires full traceability from raw material entry through batch release, including dedicated analytical monitoring and repeat release testing. All API production lines adhere to strict cross-contamination and segregation guidelines to ensure final product safety for pharmaceutical applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Pharmaceutical Formulation – Solid Dosage ManufacturingChlorambucil is directly formulated into solid dosage forms such as tablets and capsules in strictly controlled pharmaceutical environments. Manufacturers blend it with excipients including lactose monohydrate, microcrystalline cellulose, and magnesium stearate. The process flows through precise weighing, blending, compression, and, if needed, film coating, all within isolated production modules. All documentation follows validated Master Batch Records (MBRs), and every manufacturing step undergoes quality oversight per country-specific regulatory mandates to guarantee patient safety and dosage accuracy. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Reference Standard and Analytical Control MaterialPharmaceutical quality control laboratories deploy Chlorambucil with established traceability as both a reference standard and analytical control material. Our manufacturing offers custom packaging, COA traceability, and purity documentation to support qualified labs in calibration, validation, and ongoing release testing. Reference material ensures method accuracy in both identity and assay quantification with system suitability testing per regulatory filing demands. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Comparative Toxicology and Clinical Trial Material SupplyPreclinical and early-phase clinical research facilities require tightly specified Chlorambucil for comparative toxicology studies and the compounding of investigational materials. Our material supports these organizations with full chain-of-custody tracking, batch-specific analytical documentation, and cold-chain/controlled substance logistics. Supplied grades comply with research use restrictions and meet requirements for control group and investigational arms in animal studies or phase I/II clinical supply chains, with adjustments possible based on species-specific protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Chlorambucil prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in this business for decades, we know there is no room for shortcuts when it comes to active pharmaceutical ingredients. Chlorambucil stands as a good example of how meticulous control over process and purity can make or break outcomes. We synthesize Chlorambucil in-house, holding tight to a process refined through years of experience and feedback from long-term partners. Every batch leaves our hands only after passing full-spectrum analytical testing—no corners cut, no compromises on purity, and no outsourcing of critical steps. Having been part of countless production runs, we recognize subtle shifts long before the final material is released.
Our Chlorambucil is produced to a specification that aligns with internationally recognized pharmacopeias. We use the CAS number 305-03-3 to track every batch, starting from raw input materials down to packaged powder. Most commercial requests are for microcrystalline powder, pale yellow to faint beige, which reflects the highest purity without excess processing. Each gram carries our unique lot number, traceable through our supply chain, and that means quality issues—rare though they are—get traced to the source fast. We ship Chlorambucil as bulk powder or pre-measured aliquots, each batch accompanied by a full certificate of analysis including HPLC purity, related substances, water content, and melting point.
Chlorambucil specifications have evolved as analytical equipment has grown more precise. Our current product achieves an HPLC purity above 99.5%, comfortably meeting global requirements. Less is written about how water content and residual solvents can impact stability, but our data shows that limiting residual moisture to less than 0.2% supports greater shelf life and reduces degradation products. These differences show up in real-world applications, where downstream pharmaceutical formulations retain potency longer. We select packaging materials to further reduce oxygen and moisture exposure—something that matters more over the course of long-term storage than marketing departments admit.
Our process chemists understand that Chlorambucil is not just a base material—it's the backbone of key chemotherapy regimens. Our batches meet or surpass monographs for genotoxic impurities, an area where we’ve invested heavily in detection capability. Routinely, researchers ask about trace nitrosamines, and we carry out advanced LC-MS/MS screening rather than relying on outmoded techniques. Often, the users of our Chlorambucil—oncology pharmaceutical development teams—share stories about failed batches or control issues with other providers. Low-level impurities like monochlorinated byproducts, which some competitors miss, don’t escape our team’s notice.
Our knowledge of thermal and photo-stability helps partners avoid process upsets. We highlight that even minor deviations in handling—excess heat, exposure to ultraviolet light—can trigger molecular breakdown. These seemingly small differences can sabotage formulation success, so we reinforce careful storage at controlled temperatures between 2-8°C and shield the product from ambient light during processing and shipping. Users who once struggled with unexpected potency loss tell us they see marked improvements with our packaging and cold-chain logistics. These decisions grew from our own practical experience, running our reactors at scale hundreds of times and adapting controls as we learned.
One of the under-reported realities in this field is variation in upstream sourcing. Having grappled with contaminated solvent shipments and off-spec raw materials ourselves, we commit to single-source starting reagents under ironclad contracts. Our QA staff perform spot checks on every incoming lot—a practice that has saved us from potential disaster more than once. We partner directly with long-term suppliers in Europe and Asia for foundational chemicals, but the buck stops with us for full synthesis and finishing. That’s the only way we can vouch for traceability and meet the ever-more-demanding scrutiny of our pharmaceutical partners. It takes more effort, but we hold the line because the consequences of failure go beyond paperwork—they hit people’s lives.
Raw material costs may fluctuate, and that has sparked hard choices. Yet, as actual manufacturers, we refuse to sub in secondary quality inputs to cut costs. There’s no mystery that when you cut corners upstream, it haunts you downstream—whether in batch rejections, regulatory recalls, or reputational damage. By letting supply chain transparency guide us, we keep our product trusted for the long run.
Production scale may look similar from the outside, but the results rarely match. We field regular questions about differences between our Chlorambucil and material offered by aggregator “traders” or bulk resellers. Testing shows these batches often feature wider impurity profiles and lower reproducibility. We saw one such imported batch with surprising levels of oxidative degradation—undetectable unless you run deep spectral scans on each lot. Regulatory inspectors come through our facility often, and they’ve confirmed the trace element fingerprint is consistent within our own output, but shifts dramatically lot-to-lot when sourced from piecemeal providers.
Granularity and flow matter when it comes time for scaling up in tablet or capsule form. We employ specialized micronization on site, with sieving that guarantees consistency not only by particle size but density. That means less dust, fewer agglomerates, and no processing headaches for our downstream formulators. Our technical support team has helped client sites troubleshoot everything from compressibility to blending, because real-world process data trumps paper specs every time.
Consistent impurity control also distinguishes our batches. Potential cross-contamination, particularly trace amounts of other alkylators, stays off the table, because our lines run only Chlorambucil during synthesis and finishing. We routinely validate cleaning to sub-ppm standards in our reactor system—laborious work, but worth it. The result is a product that stands up to internal audits both here and in clients’ own labs.
In oncology research and pharmacy compounding, predictable performance is not optional—it is essential. Chlorambucil’s role has changed little in standard regimens for CLL, some lymphomas, and off-label as salvage therapy. The clinicians who depend on these medicines pass their requirements through the entire supply chain. We’ve walked specialists through assay data, shelf-life comparisons, and the impact of handling errors, because direct manufacturer experience matters. We know exactly how raw material handling or unstable packaging can lead to loss of potency. The feedback loop runs both ways: every unusual complaint triggers a root-cause hunt on our end, with findings fed back into improved protocols and materials selection.
Statistical batch data shows our process supports strong consistency across traditional and newer compounding approaches. The material dissolves at a predictable rate in common formulating solvents—ethanol, DMSO, and others—every time. Researchers notice if material clumps or leaves unexpected residues. We address these risks in our formulation controls, so partners aren’t caught out by unexpected solubility or flowability issues. Our technical department works shoulder-to-shoulder with compounding labs, sharing hands-on tips gathered across years of production: best ways to minimize waste, optimize dispensing, and safely repackage for administration.
Production and regulation both evolve, but in our shop, compliance is never an afterthought. Regulatory updates pass straight to our quality and analytical teams. From ICH guidance on genotoxic impurities to new EMA and FDA process rules, we track developments and proactively adjust methods. This keeps our certificates and documentation always ready for audit—no scrambling when authorities visit. We participate in voluntary proficiency trials and share anonymized results with our partners, which helps spread industry best practice and highlights new challenges before they show up in field complaints.
Long-term partners count on us to help guide answer sheets and regulatory documents through tough inspection cycles. Commonly, we prepare full toxicology and elemental impurity data ahead of schedule, so there are no regulatory last-minute scrambles. Unlike third parties who simply relay paperwork, we actually supply original batch chromatograms and spectroscopic scans. Our technical team actively fields audit questions and can open up our lab notebooks on request.
Safe handling information matters, but our biggest contribution is making sure incoming Chlorambucil won’t create headache later on. We invest in training for our own staff: refresher sessions on risk control, safe use of protective equipment, and process interventions. Documentation flows not just to external customers, but stays current among our in-house teams, so if a concern is raised—dust emissions, for example—it’s met with both expertise and firsthand experience.
Technical support goes beyond an emailed data sheet. Clients frequently lean on us for tricks learned only through many cycles of real-world troubleshooting. A recent example—one partner faced inconsistent dissolution rates in a scaled batch, which we traced to slightly increased humidity exposure during storage. Because we gather retain samples from every batch we manufacture, we replicated their conditions and diagnosed the issue within days, sharing a revised storage protocol that worked reliably for future lots. Having chemists and analysts on site willing to go into the lab, duplicate client workflows, and pinpoint inefficiencies makes a tangible difference. Our familiarity with fine process tolerances shows up in faster tech transfer and more robust process scale-up.
We also apply our knowledge to sustainability. Solvent selection and use have faced tightening rules, pushing us to continually optimize for reduced waste and safer handling. Our team works to recover and recycle solvents wherever possible, and we keep abreast of green chemistry alternatives that do not erode the chemical integrity of the product. This directly benefits clients who must account for both regulatory and environmental scorecards.
Demand for Chlorambucil remains steady, but end-users are more informed and auditing requirements have never been tougher. We respond by investing in better instrumentation and analytical capabilities, so we don’t fall behind on evolving impurity or stability standards. Our R&D program explores new formulations, from nanodispersion to co-crystallization, using the core Chlorambucil produced in our own reactors as a platform. This practical focus sharpens our production approach and ensures our clients benefit from innovation grounded in real operational experience.
Direct control over synthesis means we have the flexibility to tailor particle size distribution, batch sizing, and packaging based on ongoing feedback. During periods with global logistics delays, our decision to hold strategic buffer stocks helped partners avert critical shortages. Maintaining an explicit and open channel between the production side and those who run downstream applications shapes our priorities: reliability, open communication, and problem-solving based on firsthand data.
Decades at the reactor controls have taught us that the value of a chemical ingredient lies in building trust. Each drum of Chlorambucil represents years of accumulated knowledge and a problem-solving mind-set embedded at every production stage. By overseeing the complete synthesis, purification, and packaging steps, we produce material that meets the needs of oncology research and pharma manufacturing without caveats or workarounds.
We do not claim to be perfect, but we face each process challenge head-on, integrating new insights tightly into our workflow. A product as sensitive as Chlorambucil cannot succeed by luck or abstract protocol alone; it relies on teams who track every anomaly, make adjustments in real-time, and share knowledge openly with downstream collaborators. Feedback from our customers remains our most important tool for improvement. While differences in price or delivery time draw attention, it’s the years of hands-on experience and attention to incremental process change that delivers lasting value. The Chemists, engineers, and technicians in our shop know this from direct experience. Our commitment remains: offer Chlorambucil with full transparency, reliability, and support, because manufacturing accountability can’t be faked or outsourced.
The world doesn’t stand still, and neither do our standards. Each audit, each technical support call, and each regulatory update sharpens our focus. We maintain robust data records so we spot variability as soon as it appears—long before a product hits downstream users. Our emphasis on traceability stems from seeing the difference it makes in real operational troubleshooting.
Ultimately, our long experience as true manufacturers brings both guarantee and responsibility. We sweat the small stuff so our clients don’t have to. Chlorambucil deserves—and receives—the attention and best practice learned in the trenches. Our clients know they will always get not just a product, but a partner willing to stand with them through every challenge.